imatinib mesylate has been researched along with Aortic Aneurysm, Abdominal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Balboa Ramilo, A; Becirovic-Agic, M; Mani, K; Petri, MH; Wågsäter, D; Wanhainen, A | 1 |
Ding, L; He, Q; Wang, T; Yang, B; Yao, F; Yao, Z; Zhang, B; Zhang, J; Zhong, T | 1 |
Dugic, E; Eriksson, P; Mäyränpää, MI; Roy, J; Vikingsson, S; Vorkapic, E; Wågsäter, D | 1 |
Benjamin, RS; Blanke, CD; Blay, JY; Bonvalot, S; Eisenberg, B | 1 |
1 review(s) available for imatinib mesylate and Aortic Aneurysm, Abdominal
Article | Year |
---|---|
Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
Topics: Adult; Aged; Antineoplastic Agents; Aortic Aneurysm, Abdominal; Benzamides; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Tomography, X-Ray Computed | 2006 |
3 other study(ies) available for imatinib mesylate and Aortic Aneurysm, Abdominal
Article | Year |
---|---|
The tyrosine kinase inhibitor Bosutinib does not inhibit angiotensin II-induced abdominal aortic aneurysm: Validation of the importance of PDGFR and c-Kit tyrosine kinases by Imatinib.
Topics: Angiotensin II; Aniline Compounds; Aortic Aneurysm, Abdominal; Humans; Imatinib Mesylate; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Quinolines | 2022 |
Imatinib prevents elastase-induced abdominal aortic aneurysm progression by regulating macrophage-derived MMP9.
Topics: Animals; Aortic Aneurysm, Abdominal; Disease Progression; Gene Expression Regulation, Enzymologic; Imatinib Mesylate; Macrophages; Male; Matrix Metalloproteinase 9; Pancreatic Elastase; Phosphorylation; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor | 2019 |
Imatinib treatment attenuates growth and inflammation of angiotensin II induced abdominal aortic aneurysm.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Apoptosis; CD3 Complex; Chymases; Humans; Imatinib Mesylate; Inflammation; Male; Mast Cells; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Signal Transduction | 2016 |